Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer.
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Zhi
Z
Hu
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA.
Jian-Hua
JH
Mao
Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Christina
C
Curtis
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Ge
G
Huang
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Shenda
S
Gu
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Laura
L
Heiser
Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, 02215, USA.
Marc E
ME
Lenburg
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
James E
JE
Korkola
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94127, USA.
Nora
N
Bayani
MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK.
Shamith
S
Samarajiwa
Department of Medicine, Division of Oncology and Department of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Jose A
JA
Seoane
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Mark A
MA
Dane
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Amanda
A
Esch
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Heidi S
HS
Feiler
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Nicholas J
NJ
Wang
GlaxoSmithKline, Collegeville, PA, 19425, USA.
Mary Ann
MA
Hardwicke
GlaxoSmithKline, Collegeville, PA, 19425, USA.
Sylvie
S
Laquerre
GlaxoSmithKline, Collegeville, PA, 19425, USA.
Jeff
J
Jackson
Cytokinetics, Inc., South San Francisco, CA, 94080, USA.
Kenneth W
KW
Wood
GlaxoSmithKline, Collegeville, PA, 19425, USA.
Barbara
B
Weber
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA.
Paul T
PT
Spellman
Molecular Oncology, BC Cancer Research Centre, Vancouver, Canada.
Samuel
S
Aparicio
GlaxoSmithKline, Collegeville, PA, 19425, USA.
Richard
R
Wooster
Cancer Research UK, Cambridge Institute, Cambridge, UK. carlos.caldas@cancer.org.uk.
Carlos
C
Caldas
Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, 3303 SW Bond Ave., CH13B, Portland, OR, 97239, USA. Grayjo@ohsu.edu.
Joe W
JW
Gray